Developing, funding and conducting clinical trials in immune tolerance

LITTMUS | A clinical trial for liver transplant candidates

Are you waiting for a

liver transplant?

The LITTMUS Study

A clinical study testing a new approach using T regulatory cells to possibly stop anti-rejection medications after liver transplantation.

 

Learn more ›

Eligibility

If you are 18+ and are a liver transplant candidate, you may be eligible to participate in LITTMUS.

 

Learn more ›

Study Location

LITTMUS is being conducted at MGH in Boston, MA.

 

Learn more ›